CXCL12 and cancer: The strict interaction between cancer cells and TME alters and damages the stromal structure leading to the release of signal proteins such as SDF-1 (CXCL12) and its receptor called CXCR4; the overexpression of these molecules is associated with cancer progression [64,65].